Evidence map›Paper›PMID 24418559›Full record

ArticleVirology2014

Cellular transcription factor YY1 mediates the varicella-zoster virus (VZV) IE62 transcriptional activation.

Mohamed I Khalil, Marvin Sommer, Ann Arvin, John Hay, William T Ruyechan

Abstract read
In one paragraph

Article in Virology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.4field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Dual Role of YY1 in HPV Life Cycle and Cervical Cancer Development.International journal of molecular sciences · 2022
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Mohamed I KhalilDepartments of Pediatrics and Microbiology & Immunology, Stanford University School of Medicine, Stanford, CA 94305, United States; Department of Molecular Biology, National Research Center, Dokki, Cairo, Egypt. Electronic address: mkhalil2@stanford.edu.
Marvin SommerDepartments of Pediatrics and Microbiology & Immunology, Stanford University School of Medicine, Stanford, CA 94305, United States.
Ann ArvinDepartments of Pediatrics and Microbiology & Immunology, Stanford University School of Medicine, Stanford, CA 94305, United States.
John HayDepartment of Microbiology and Immunology and the Witebsky Center for Microbial Pathogenesis and Immunology, University at Buffalo, Buffalo, NY, United States.
William T RuyechanDepartment of Microbiology and Immunology and the Witebsky Center for Microbial Pathogenesis and Immunology, University at Buffalo, Buffalo, NY, United States.
Stanford University · USUniversity at Buffalo, State University of New York · USNational Research Centre · EG

Funding

Varicella-Zoster Virus: T Cell/Skin Tropisms &ImmunityR01AI020459 · NIAID · STANFORD UNIVERSITY · PI OLIVER, STEFAN LYNE · 1985 to 2023
$6.4M
Varicella-zoster Virus: Tegument Proteins in PathogenesisR01AI053846 · NIAID · STANFORD UNIVERSITY · PI ARVIN, ANN · 2003 to 2012
$4.1M
Varicella-Zoster Virus: T Cell/Skin Tropisms & ImmunityR37AI020459 · NIAID · STANFORD UNIVERSITY · PI ARVIN, ANN · 2016 to 2020
$2.0M
Structure/Function of Varicella Zoster Virus DNAR01AI018449 · NIAID · U.S. UNIFORMED SERVICES UNIV OF HLTH SCI · PI RUYECHAN, WILLIAM T · 1985 to 2007
$1.8M
Structure/Function of Varicella Zoster Virus DNA.R56AI018449 · NIAID · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI HAY, JOHN I. · 2008 to 2009
$788k
Structure/Function of Varicella Zoster Virus DNAR21AI018449 · NIAID · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI RUYECHAN, WILLIAM T · 2002 to 2002
$304k
NIAID NIH HHS AI018449NIAID NIH HHS AI020459NIAID NIH HHS AI053846NIAID NIH HHS R01 AI018449NIAID NIH HHS R01 AI020459NIAID NIH HHS R01 AI053846NIAID NIH HHS R21 AI018449NIAID NIH HHS R37 AI020459NIAID NIH HHS R56 AI018449
6 · The paper itself

Abstract

Several cellular transcription factors have been shown to be involved in IE62-mediated activation. The YY1 cellular transcription factor has activating and repressive effects on gene transcription. Analysis of the VZV genome revealed 19 postulated YY1 binding sites located within putative promoters of 16 VZV genes. Electrophoretic mobility shift assays (EMSA) confirmed the binding of YY1 to ORF10, ORF28/29 and gI promoters and the mutation of these binding sites inhibited YY1 binding and the promoter activation by IE62 alone or following VZV infection. Mutation of the ORF28/29 YY1 site in the VZV genome displayed insignificant influence on virus growth in melanoma cells; but it inhibited the virus replication significantly at day 5 and 6 post infection in HELF cells. This work suggests a novel role for the cellular factor YY1 in VZV replication through the mediation of IE62 activation of viral gene expression.

Indexed as

Gene Expression Regulation, ViralTranscriptional ActivationCell Line, TumorHerpesvirus 3, HumanHerpes ZosterHumansImmediate-Early ProteinsPromoter Regions, GeneticProtein BindingTrans-ActivatorsViral Envelope ProteinsYY1 Transcription FactorIE62 protein, Human herpesvirus 3Immediate-Early ProteinsTrans-ActivatorsViral Envelope ProteinsYY1 Transcription FactorgIIE62ORF10ORF28/29PromotersTranscriptionVZVYY1

Identifiers

PMID24418559
PMCPMC3901949
OpenAlexW2031704607

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.